SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000950112-96-000421
Filing Date
1996-02-13
Accepted
1996-02-13 00:00:00
Documents
1
Confirming Copy
 
Group Members
ALBERTO W. VILARAMERINDO INVESTMENT ADVISORS (U.K.), LIMITEDAMERINDO INVESTMENT ADVISORS INCAMERINDO INVESTMENT ADVISORS INC., PANAMA CORP.GARY A. TANAKA
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 SEQUUS PHARMACEUTICALS, INC. SC 13D 33097
  Complete submission text file 0000950112-96-000421.txt   35456
Mailing Address 960 HAMILTON CT MENLO PARK CA 94025
Business Address 960 HAMILTON COURT MENLO PARK CA 94025 (415)-323-90
SEQUUS PHARMACEUTICALS INC (Subject) CIK: 0000812444 (see all company filings)

IRS No.: 943031834 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-39102 | Film No.: 00000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE EMBARCADERO CENTER STE 2300 SAN FRANCISCO CA 94111
Business Address ONE EMBARCADERO CENTER STE 2300 SAN FRANCISCO CA 94111 4153620292
AMERINDO INVESTMENT ADVISORS INC (Filed by) CIK: 0000860655 (see all company filings)

IRS No.: 942997472 | State of Incorp.: CA | Fiscal Year End: 0430